Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study

Background: Tofacitinib (TOFA) was the first Janus kinase inhibitor (JAKi) to be approved for the treatment of rheumatoid arthritis (RA). However, data on the retention rate of TOFA therapy are still far from definitive. Objective: The goal of this study is to add new real-world data on the TOFA ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Paroli, Marino, Becciolini, Andrea, Bravi, Elena, Andracco, Romina, Nucera, Valeria, Parisi, Simone, Ometto, Francesca, Lumetti, Federica, Farina, Antonella, Del Medico, Patrizia, Colina, Matteo, Lo Gullo, Alberto, Ravagnani, Viviana, Scolieri, Palma, Larosa, Maddalena, Priora, Marta, Visalli, Elisa, Addimanda, Olga, Vitetta, Rosetta, Volpe, Alessandro, Bezzi, Alessandra, Girelli, Francesco, Molica Colella, Aldo Biagio, Caccavale, Rosalba, Di Donato, Eleonora, Adorni, Giuditta, Santilli, Daniele, Lucchini, Gianluca, Arrigoni, Eugenio, Platè, Ilaria, Mansueto, Natalia, Ianniello, Aurora, Fusaro, Enrico, Ditto, Maria Chiara, Bruzzese, Vincenzo, Camellino, Dario, Bianchi, Gerolamo, Serale, Francesca, Foti, Rosario, Amato, Giorgio, De Lucia, Francesco, Dal Bosco, Ylenia, Foti, Roberta, Reta, Massimo, Fiorenza, Alessia, Rovera, Guido, Marchetta, Antonio, Focherini, Maria Cristina, Mascella, Fabio, Bernardi, Simone, Sandri, Gilda, Giuggioli, Dilia, Salvarani, Carlo, Franchina, Veronica, Molica Colella, Francesco, Ferrero, Giulio, Ariani, Alarico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456797/
https://www.ncbi.nlm.nih.gov/pubmed/37629770
http://dx.doi.org/10.3390/medicina59081480

Ejemplares similares

Ejemplares similares